Therapeutics
Learn More About Cervical Dystonia with Dr. Joseph Jankovic
DaxibotulinumtoxinA for Injection is an investigational agent that has not been approved by the FDA.
Clinical Highlights
Therapeutics
Revance Announces Top-Line Results for ASPEN-1
DaxibotulinumtoxinA for Injection is an investigational agent that has not been approved by the FDA.
Therapeutics
Injectable DaxibotulinumtoxinA in Cervical Dystonia: A Phase 2 Dose-Escalation Multicenter Study
Movement Disorders
- Author: Joseph Jankovic M.D. et al
Disclaimers
DaxibotulinumtoxinA for Injection is an investigational agent that has not been approved by the FDA. Anticipated approval in 2020
* DaxibotulinumtoxinA for Injection was formerly known as RT002.